Else Nutrition Stock Forecast, Price & News

+0.06 (+2.14 %)
(As of 07/27/2021 03:58 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume155,419 shs
Average Volume127,859 shs
Market CapitalizationC$271.52 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for Else Nutrition and its competitors with MarketBeat's FREE daily newsletter.

About Else Nutrition

Else Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products to the infant, toddler, children, and adult markets. It offers baby snacks under the HEART brand; baby feeding accessories, such as feeding bottles and disposable sterile nipples (teats); baby formulas; and nutritional drinks, as well as dried food snacks. Else Nutrition Holdings Inc. is headquartered in Tel Aviv-Yafo, Israel.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.44 out of 5 stars

Analyst Opinion: 3.0Community Rank: 4.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Else Nutrition (CVE:BABY) Frequently Asked Questions

Is Else Nutrition a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Else Nutrition in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Else Nutrition stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BABY, but not buy additional shares or sell existing shares.
View analyst ratings for Else Nutrition
or view top-rated stocks.

What stocks does MarketBeat like better than Else Nutrition?

Wall Street analysts have given Else Nutrition a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Else Nutrition wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Else Nutrition's stock been impacted by COVID-19?

Else Nutrition's stock was trading at C$0.80 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BABY stock has increased by 258.8% and is now trading at C$2.87.
View which stocks have been most impacted by COVID-19

What price target have analysts set for BABY?

1 Wall Street analysts have issued 1-year target prices for Else Nutrition's stock. Their forecasts range from C$6.50 to C$6.50. On average, they anticipate Else Nutrition's share price to reach C$6.50 in the next year. This suggests a possible upside of 126.5% from the stock's current price.
View analysts' price targets for Else Nutrition
or view top-rated stocks among Wall Street analysts.

Who are Else Nutrition's key executives?

Else Nutrition's management team includes the following people:
  • Ms. Hamutal Yitzhak, Co-Founder, Chairman & CEO (Age 53, Pay $141.91k)
  • Mr. Uriel Kesler, Co-Founder, COO & Director (Age 61, Pay $137.67k)
  • Mr. Shay Shamir, CFO & Corp. Sec.
  • Mr. Michael Azar, Co-Founder & CTO
  • Mr. Reuben Halevi, VP of Sales Operations (Age 64)
  • Ms. Liliana Frimerman, Head of Bookkeeping & Payroll
  • Ms. Chelsie Hodge, Director of Corp. Relations

Who are some of Else Nutrition's key competitors?

What other stocks do shareholders of Else Nutrition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Else Nutrition investors own include iQIYI (IQ), Bank of Queensland (BOQ), Nokia (NOK), CV Sciences (CVSI), iSIGN Media Solutions (ISD), Nikola (NKLA), Nokia Oyj (NOKIA), Royal Dutch Shell (RDSB), AeroVironment (AVAV) and (ASAN).

What is Else Nutrition's stock symbol?

Else Nutrition trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BABY."

How do I buy shares of Else Nutrition?

Shares of BABY and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Else Nutrition's stock price today?

One share of BABY stock can currently be purchased for approximately C$2.87.

How much money does Else Nutrition make?

Else Nutrition has a market capitalization of C$271.52 million and generates C$2.32 million in revenue each year.

What is Else Nutrition's official website?

The official website for Else Nutrition is

This page was last updated on 7/28/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.